Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $2.1B bought by 553 insiders at 344 companies
- $9.7B sold by 664 insiders outside a trading plan
- $4.6B sold by 964 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past month · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$595M
-
RSGRepublic Services, Inc.Cascade Investment, L.l.c.10% owner · +1 joint filer$454M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$179M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$158M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.5M
-
GMEGameStop CorporationRyan CohenCEO$74.4M
-
FTKFlotek Industries, Inc.Matthew WilksDirector$34.3M
-
PAMTPamt Corp.Matthew T MorounDirector$31.2M
-
GRABGrab Holdings LimitedAnthony Ping Yeow TanCEO$29.9M
Biggest sales
Past month · by insider, all their filings added up · planned sales marked
-
FANGDiamondback Energy, Inc.SGF FANG Holdings, LP10% owner · +1 joint filer$3.7B
-
MDLNMedline Inc.GIC Private Ltd10% owner · +2 joint filers$722M
-
NVDANvidia Corporation ComMark A StevensDirector$536M
-
INGMIngram Micro Holding CorporationPlatinum Equity, LLC10% owner · +9 joint filers$410M
-
IHTInnSuites Hospitality TrustMarc E BergEVP & Secretary/Treasurer$361M
-
DELLDell Technologies Inc.Silver Lake Partners IV, L.P.Director · +4 joint filers$356M
-
DELLDell Technologies Inc.Sl Spv-2, L.P.Director · +4 joint filers$289M
-
AVGOBroadcom Inc.Henry SamueliDirector$250M
-
CHYMChime Financial, Inc.DST Global Advisors Ltd10% owner · +9 joint filers$237M
-
UMCUnited Microelectronics CorporationChitung LiuCFO$229M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Che-Chia Wei CEO, Yung-Pei Chin COO, Kevin Xiaoqiang Zhang COO, Shien-Yang Wu SVP, +17 more
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Milena Maria Pappa Director, Raffaele Zagari Director, Symeon Spyrou CFO, Nikolaos Reskos COO, +3 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Christopher J Abate CEO, Dashiell I Robinson President, Greg H Kubicek Director, Brooke Carillo CFO, +2 more
-
Matthew G De Soto Director, Albert J. Evans Director, Rory G Ritrievi CEO, Joel L. Frank Director, +2 more
-
Ryan Cohen CEO, Lawrence Cheng Director, Alain Attal Director, Nat Turner Director, +1 more
-
Tricor PMT25 Holdings Inc. 10% owner, H Sanford Riley Chair, Nicholas Peters Director, Marc Sheinbaum Director, +1 more
-
Avenue RP Opportunities Fund, L.P. 10% owner, Par Chadha Director, Avenue Global Opportunities Master Fund LP 10% owner, Andrej Jonovic CEO, +1 more
-
Lawrence B Seidman Director, Eric J Dale Director, Carl M Porto Director, Jeffrey R Dunne Director, +1 more
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
Paul A Mahon EVP & General CounselUTHRUnited Therapeutics CorporationPlanned sale$4.7M 8,300 shares at $564.95 16% of stakeTraded Oct 1 Filed Oct 1
-
Milton C Ault III DirectorUUUUniversal Safety Products, Inc.Buy$92.4M 18,000 shares at $5,134.00 +1.6% to stakeTraded Sep 30 Filed Oct 1
-
D Jonathan Merriman DirectorPODCPodcastOne, Inc.Buy$15K 7,000 shares at $2.21 +1.8% to stakeTraded Sep 30 Filed Oct 1
-
Cesar Nivaldo Gon CEOCINTCI&T IncBuy$20K 6,684 shares at $3.01 +8.9% to stakeTraded Sep 29–30 Filed Oct 1
-
Neto Bruno Guicardi Pres. of N. Am. /Europe OpsCINTCI&T IncBuy$8,410 2,825 shares at $2.98 +2.9% to stakeTraded Sep 29–30 Filed Oct 1
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$1.1M 1,920 shares at $550.22 0.6% of stakeTraded Sep 30 Filed Oct 1
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$3.9M 7,580 shares at $517.97 2.3% of stakeTraded Sep 30 Filed Oct 1
-
Nello Mainolfi CEOKYMRKymera Therapeutics, Inc.Planned sale$3.4M 30,000 shares at $113.80 4.3% of stakeTraded Oct 1 Filed Oct 1
-
AWM Investment Company, Inc. 10% ownerMASS908 Devices Inc.Sale$207K 18,000 shares at $11.52 0.4% of stakeTraded Sep 29 Filed Oct 1
-
Matthew Barnes President - Foot Locker IntlDKSDick's Sporting Goods IncBuy$500K 3,665 shares at $136.39 +44% to stakeTraded Sep 30 Filed Oct 1
-
Chi Fung Cheng Chief Technology OfficerCRDOCredo Technology Group Holding LtdPlanned sale$5.3M 27,500 shares at $193.93 0.5% of stakeTraded Sep 29 Filed Oct 1
-
William Staples CEOGTLBGitLab Inc.Buy$125K 2,677 shares at $46.62 +0.4% to stakeTraded Sep 30 Filed Oct 1
-
Robert D Vilsack Secretary & CLOPKOHPark-Ohio Holdings Corp.Planned sale$90K 1,941 shares at $46.54 1.3% of stakeTraded Sep 30 Filed Oct 1
-
Ryan M. Daniels SVP, Wood ProductsRYNRayonier Inc.Planned sale$16K 887 shares at $18.56 1.6% of stakeTraded Sep 30 Filed Oct 1
-
David Brian Miller DirectorONTOOnto Innovation Inc.Planned sale$600K 2,000 shares at $300.00 16% of stakeTraded Sep 29 Filed Oct 1
-
Opaleye Management Inc. 10% ownerGRCEGrace Therapeutics, Inc.Buy$16K 7,849 shares at $2.09 +0.3% to stakeTraded Sep 29 Filed Oct 1
-
George Kurian CEONTAPNetApp, Inc.Planned sale$10.5M 50,000 shares at $209.95 19% of stakeTraded Sep 29 Filed Oct 1
-
Haim Chera EVP - Head of RetailVNOVornado Realty TrustSale$3.1M 90,000 shares at $34.01 45% of stakeTraded Sep 29 Filed Oct 1
-
Cheryl Gault COORAPPRapport Therapeutics, Inc.Planned sale$332K 10,000 shares at $33.19 6.7% of stakeTraded Sep 30 Filed Oct 1
-
Genworth Holdings, Inc. 10% ownerACTEnact Holdings, Inc.Sale$37.1M 762,894 shares at $48.65 0.7% of stakeTraded Sep 30 Filed Oct 1
-
Tobin W Juvenal Chief Commercial OfficerCSTLCastle Biosciences, Inc.Planned sale$232K 6,577 shares at $35.29 11% of stakeTraded Sep 29–30 Filed Oct 1
-
Robert D Vilsack Secretary & CLOPKOHPark-Ohio Holdings Corp.Planned sale$355K 7,640 shares at $46.41 4.7% of stakeTraded Sep 29–30 Filed Oct 1
-
John O Larsen DirectorPCGPG&E CorpBuy$92K 7,500 shares at $12.20 +26% to stakeTraded Sep 30 Filed Oct 1
-
Matthew J Cox CEOMATXMatson, Inc.Planned sale$2.2M 10,000 shares at $222.33 4.4% of stakeTraded Sep 29 Filed Oct 1
-
Life Insurance Co Nippon 10% ownerCRBGCorebridge Financial Inc.Buy$7.3M 216,818 shares at $33.67 +0.2% to stakeTraded Sep 29 Filed Oct 1
-
Nicole Lamb-Hale DirectorFRTFederal Realty Investment TrustSale$163K 1,500 shares at $108.89 25% of stakeTraded Sep 30 Filed Oct 1
-
Tammy L Martin General Counsel and SecretaryCTMCastellum, Inc.Buy$747 1,396 shares at $0.5400 +9.3% to stakeTraded Oct 1 Filed Oct 1
-
Glen R Ives CEOCTMCastellum, Inc.Buy$910 1,700 shares at $0.5400 +0.8% to stakeTraded Oct 1 Filed Oct 1
-
William B Gordon DirectorTTWOTake-Two Interactive Software, Inc.Planned sale$2M 10,000 shares at $202.39 18% of stakeTraded Sep 29 Filed Oct 1
-
Atul Dandekar CsboMAZEMaze Therapeutics, Inc.Planned sale$203K 7,500 shares at $27.06 19% of stakeTraded Sep 29 Filed Oct 1
-
Mei Kanayama Representative Director (PEO)TKLFTokyo Lifestyle Co., Ltd.Buy$383K 1,396,755 shares at $0.2700 +19% to stakeTraded Sep 29 Filed Oct 1
-
John C Malone 10% ownerLILALiberty Latin America Ltd.Buy$168K 20,000 shares at $8.40 +6.5% to stakeTraded Sep 30 Filed Oct 1
-
Alfred P West Jr. InsiderSEICSEI Investments CompanySale$3.5M 33,877 shares at $103.36 0.5% of stakeTraded Sep 29–30 Filed Oct 1
-
Opaleye Management Inc. 10% ownerGRCEGrace Therapeutics, Inc.Buy$32K 15,089 shares at $2.10 +0.5% to stakeTraded Sep 21–23 Filed Oct 1
-
Derek Gordon Schiller EVP, BusinessBATRKAtlanta Braves Holdings, Inc.Planned sale$9.3M 175,395 shares at $53.20 36% of stakeTraded Sep 30 Filed Oct 1
-
Gregory John Heller EVP, CLO & SecretaryBATRKAtlanta Braves Holdings, Inc.Planned sale$4.3M 80,263 shares at $53.89 78% of stakeTraded Sep 29 Filed Oct 1
-
Richard D Gebert DirectorIRTIndependence Realty Trust, Inc.Planned sale$7,235 500 shares at $14.47 1.2% of stakeTraded Oct 1 Filed Oct 1
-
Corazon (Corsee) D. Sanders DirectorLEGNLegend Biotech CorporationSale$259K 27,370 shares at $9.46 34% of stakeTraded Sep 29 Filed Oct 1
-
Matthew M. Kim ComptrollerSOSouthern Company (The)Planned sale$8,273 100 shares at $82.73 2% of stakeTraded Oct 1 Filed Oct 1
-
Robert D Vilsack Secretary & CLOPKOHPark-Ohio Holdings Corp.Planned sale$306K 6,497 shares at $47.11 3.9% of stakeTraded Sep 29 Filed Oct 1
-
Peggy Roe DirectorSPGSimon Property Group, Inc.Buy$18K 88 shares at $202.78 +1.1% to stakeTraded Sep 30 Filed Oct 1
-
Realty Advisors Inc. 10% ownerGBRNew Concept Energy, IncBuy$2M 2,000,000 shares at $1.00 +500% to stakeTraded Sep 29 Filed Oct 1
-
Horizon Kinetics Asset Management LLC 10% ownerTPLTexas Pacific Land CorporatiBuy$1,364 4 shares at $340.96 +<0.1% to stakeTraded Sep 29 Filed Oct 1
-
Marta R Stewart DirectorSPGSimon Property Group, Inc.Buy$40K 199 shares at $202.78 +1.1% to stakeTraded Sep 30 Filed Oct 1
-
Daniel C. Smith DirectorSPGSimon Property Group, Inc.Buy$71K 350 shares at $202.78 +1% to stakeTraded Sep 30 Filed Oct 1
-
Stefan M Selig DirectorSPGSimon Property Group, Inc.Buy$42K 208 shares at $202.78 +0.6% to stakeTraded Sep 30 Filed Oct 1
-
Gary M Rodkin DirectorSPGSimon Property Group, Inc.Buy$47K 232 shares at $202.78 +1.1% to stakeTraded Sep 30 Filed Oct 1
-
Randall J Lewis DirectorSPGSimon Property Group, Inc.Buy$13K 65 shares at $202.78 +0.9% to stakeTraded Sep 30 Filed Oct 1
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,792 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.